Clinical trial Recruiting at 1 site Observational Ages 2 to 90

Cross-modal in vivo imaging of skin microstructure

Official title: In Vivo Cross-Modal Imaging of Skin - VISION2

Run by Enspectra Health · NCT07188948 · Data updated 2026-11-12

This project will use a handheld imaging device (VIO/FG-30350) to see if microscopic skin features correspond to visible skin appearance in people aged 2 to 90 with different skin health.

Quick facts

Study typeObservational
Ages2 Years to 90 Years
SexAll
Enrollment15 (estimated)
SponsorEnspectra Health
Industry-sponsored
Locations1 site (Mountain View, California)
StatusRecruiting
StartedSeptember 2, 2025
Main results expectedSeptember 30, 2025
Study endsSeptember 30, 2025
Registry record updatedSeptember 23, 2025
Trial IDNCT07188948 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 2–90 with varying skin health who can provide informed consent (or have a guardian provide consent), comply with protocol visits, and give feedback about device use.

Probably not a fit

People seeking therapeutic treatment benefit, those with general health conditions that increase procedural risk, or those unable to consent or comply with protocol procedures are unlikely to receive direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study uses the VIO/FG-30350 device to capture microscopic images of skin at multiple anatomic locations in participants with a range of skin health. Investigators will compare those microscopic features with macroscopic (visible) skin characteristics to identify correlations. Participants aged 2–90 who can consent (or whose guardians can consent) and provide feedback will undergo noninvasive imaging during study visits. Anonymized data will be shared with the sponsor and regulatory bodies for analysis.

Why it matters

Potential benefit: If successful, this could improve noninvasive skin evaluation by linking microscopic imaging patterns to visible clinical signs, aiding earlier and more precise diagnosis or monitoring.

How similar studies have gone: Related noninvasive microscopic skin imaging methods (such as reflectance confocal microscopy and OCT) have clinical precedent, but using VIO/FG-30350 for cross-modal correlation of microscopic and macroscopic features is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants, ages 2 - 90 years old

Participant, or guardian, if applicable, must be willing to provide written informed consent prior to enrollment and agree to comply with protocol requirements. If applicable, child must be willing to provide written assent prior to enrollment and agree to comply with protocol requirements.

Participant or guardian, if applicable, must have sufficient mental capacity to understand the Informed Consent and provide clinically relevant and reliable feedback regarding their experience with the device.

Participant and guardian, if applicable, must comply with the protocol requirements.

Participant or guardian, if applicable, must agree that anonymized personal data will be made available to Study Sponsor and requisite regional and international regulatory bodies

Exclusion Criteria:

Any general health condition or systemic disease that may represent, in the opinion of the Principal Investigator, a potential increased risk associated with device use

Currently infected with a communicable skin infection (e.g., shingles or methicillin-resistant S. aureus), which does not include local and minimally pathogenic or non-pathogenic infections distant from the imaging location(s) (e.g., warts, acne)

Any known allergies to any materials used in the preparation of skin and/or device use

Has a temporary or permanent electrical implanted medical device

\-

Where it's running

  • Enspectra Health
    Mountain View, California, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.